Messenger RNA (mRNA) vaccines are a prime example of
the promising field of nanomedicine. But progress in the design and
application of nanoparticles as efficient delivery vehicles for
biopharmaceutics containing nucleic acid or protein drug substances
is, unfortunately, remarkably slow.